Microbial cancer therapeutics: A promising approach

Area of Science:

• Biochemistry
• Microbiology
• Pharmacology

Background:

• Conventional cancer therapeutics face limitations including severe side-effects, antibiotic resistance, and lack of drug selectivity.
• There is a growing need for anti-cancer agents that specifically target cancer cells, sparing healthy tissues.
• Microbial-derived bioactive molecules are emerging as a promising area for novel cancer treatment strategies.

Purpose of the Study:

• To comprehensively review the anti-carcinogenic properties of microbial bioactive molecules.
• To elucidate the underlying mechanisms by which these molecules exert their anti-cancer effects.
• To discuss challenges and explore combinatorial strategies for effective cancer therapy with minimal side-effects.

Main Methods:

• Literature review of scientific publications on microbial-derived anti-cancer agents.
• Analysis of studies detailing the mechanisms of action of these bioactive molecules.
• Examination of research on combinatorial therapeutic approaches.

Main Results:

• Microbial compounds exhibit diverse anti-cancer activities, including cytotoxicity, apoptosis induction, and anti-angiogenesis.
• Specific molecular pathways targeted by microbial agents have been identified.
• Combinatorial strategies show potential for enhanced efficacy and reduced systemic toxicity.

Conclusions:

• Microbial bioactive molecules represent a valuable resource for developing selective and effective anti-cancer drugs.
• Understanding their mechanisms is crucial for optimizing therapeutic applications.
• Further research into combinatorial approaches is warranted to overcome current therapeutic challenges.